首页> 外国专利> (D9) - venturin

(D9) - venturin

机译:(D9)-文图林

摘要

Medical chemical constituents, neurotransmitters and acceptable salt intake of kappa alpha__inhibitors and their proxies were introduced. These______, deal with and/or manage generalized disturbances of mental disorders, anxiety disorders, depression, and anxiety disorders, 32 stress, obsessive compulsive disorder, panic disorder,Tidal fever ("hot flashes"), Alzheimer's disease, migraine, chronic pain syndrome, 95eta lambda_ __delta____dipole obstructive sleep apnea, depression, psychiatric disorders, pio_rho_________disorders, social phobia The psychology of social anxiety, urinary incontinence, anorexia, gluttony,Obesity trauma, ischemia, scalp, brain cell calcium overload, drug dependence, attention deficit hyperactivity disorder, and high Irritable bowel syndrome fibromyalgia, mobility, and / or premature ejaculation.
机译:介绍了kappaα_抑制剂及其代理的药用化学成分,神经递质和可接受的盐摄入量。这些______用于治疗和/或管理精神障碍,焦虑症,抑郁和焦虑症,32压力,强迫症,惊恐症,潮热(“潮热”),阿尔茨海默氏病,偏头痛,慢性疼痛综合征,95 beta lambda_偶极阻塞性睡眠呼吸暂停,抑郁症,精神疾病,pio_rho ___________疾病,社交恐惧症社会焦虑症,尿失禁,厌食症,暴食,肥胖症的心理学,局部缺血,头皮,脑细胞钙超载,药物依赖,注意缺陷多动障碍和高肠易激综合征纤维肌痛,活动性和/或早泄。

著录项

  • 公开/公告号CY1118174T1

    专利类型

  • 公开/公告日2017-06-28

    原文格式PDF

  • 申请/专利权人 AUSPEX PHARMACEUTICALS INC.;

    申请/专利号CY201611001104T

  • 申请日2016-10-31

  • 分类号C07C217/74;C07B59;C07C211/64;C07C215/64;C07D265/16;

  • 国家 CY

  • 入库时间 2022-08-21 13:39:35

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号